lisofylline has been researched along with Autoimmune Diabetes in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (66.67) | 29.6817 |
| 2010's | 1 (11.11) | 24.3611 |
| 2020's | 2 (22.22) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Cui, P; Macdonald, TL; Nadler, JL | 1 |
| Chitkara, D; Italiya, KS; Mittal, A; Narisepalli, S; Singh, AK | 1 |
| Basak, M; Chitkara, D; Italiya, KS; Mazumdar, S; Mittal, A; Sahel, DK; Shrivastava, R | 1 |
| Chitkara, D; Italiya, KS; Mittal, A; Singh, AK | 1 |
| Chen, M; McDuffie, M; Nadler, JL; Wu, R; Yang, ZD | 1 |
| Chen, M; Ellett, JD; Fialkow, LB; Nadler, JL; Wu, R; Yang, Z | 1 |
| Carter, JD; Chen, M; Ellett, JD; Fialkow, LB; Nadler, JL; Yang, Z | 1 |
| Chen, M; Nadler, JL; Yang, Z | 1 |
| Carter, JD; Chen, M; Garmey, JC; Kimble, SD; Nadler, JL; Nunemaker, CS; Yang, Z | 1 |
1 review(s) available for lisofylline and Autoimmune Diabetes
| Article | Year |
|---|---|
Lisofylline: a potential lead for the treatment of diabetes.
Topics: Animals; Diabetes Mellitus, Type 1; Humans; Islets of Langerhans; Pentoxifylline | 2005 |
8 other study(ies) available for lisofylline and Autoimmune Diabetes
| Article | Year |
|---|---|
Synthesis and biological evaluation of lisofylline (LSF) analogs as a potential treatment for Type 1 diabetes.
Topics: Animals; Apoptosis; Cell Line; Chemoprevention; Cytokines; Diabetes Mellitus, Type 1; Drug Evaluation, Preclinical; Hypoglycemic Agents; Insulin; Insulin Secretion; Insulin-Secreting Cells; Mice; Molecular Structure; Pentoxifylline; Stereoisomerism | 2006 |
Role of Chain Length and Degree of Unsaturation of Fatty Acids in the Physicochemical and Pharmacological Behavior of Drug-Fatty Acid Conjugates in Diabetes.
Topics: Animals; Cell Line; Diabetes Mellitus, Type 1; Dose-Response Relationship, Drug; Fatty Acids; Hypoglycemic Agents; Mice; Molecular Structure; Prodrugs; Rats; Rats, Wistar; Streptozocin; Structure-Activity Relationship | 2021 |
Scalable Self-Assembling Micellar System for Enhanced Oral Bioavailability and Efficacy of Lisofylline for Treatment of Type-I Diabetes.
Topics: Animals; Cell Line, Tumor; Cell Proliferation; Cells, Cultured; Diabetes Mellitus, Type 1; Freeze Drying; Interferon-gamma; Male; Mice; Micelles; Pentoxifylline; Rats; Rats, Wistar; Treatment Outcome; Tumor Necrosis Factor-alpha | 2019 |
Nanoparticulate tablet dosage form of lisofylline-linoleic acid conjugate for type 1 diabetes: in situ single-pass intestinal perfusion (SPIP) studies and pharmacokinetics in rat.
Topics: Administration, Oral; Animals; Cell Line; Cell Survival; Diabetes Mellitus, Type 1; Dosage Forms; Jejunum; Linoleic Acid; Male; Mice; Nanoparticles; Pentoxifylline; Perfusion; Rats; Rats, Wistar; Tablets | 2021 |
The anti-inflammatory compound lisofylline prevents Type I diabetes in non-obese diabetic mice.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Blood Glucose; Cytokines; Diabetes Mellitus, Type 1; DNA Damage; Female; Incidence; Insulin; Insulin Secretion; Islets of Langerhans; Lymphocyte Transfusion; Mice; Mice, Inbred NOD; Mice, SCID; Pentoxifylline; Spleen | 2002 |
Inhibition of STAT4 activation by lisofylline is associated with the protection of autoimmune diabetes.
Topics: Diabetes Mellitus, Type 1; DNA-Binding Proteins; Humans; Immunosuppressive Agents; Interleukin-12; Pentoxifylline; Phosphorylation; Signal Transduction; STAT4 Transcription Factor; Trans-Activators | 2003 |
The novel anti-inflammatory agent lisofylline prevents autoimmune diabetic recurrence after islet transplantation.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Apoptosis; Cytokines; Diabetes Mellitus, Type 1; Female; Graft Survival; Inflammation Mediators; Insulin; Insulin Secretion; Islets of Langerhans; Islets of Langerhans Transplantation; Mice; Mice, Inbred NOD; Mice, SCID; Pentoxifylline; Secondary Prevention; Time Factors; Transplantation, Homologous | 2004 |
Combined treatment with lisofylline and exendin-4 reverses autoimmune diabetes.
Topics: Animals; Diabetes Mellitus, Type 1; Drug Combinations; Exenatide; Insulin-Secreting Cells; Mice; Mice, Inbred C57BL; Pentoxifylline; Peptides; Treatment Outcome; Venoms | 2006 |